MDxHealth
MDxHealth Prices $40M Public Offering
The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million.
In Brief This Week:, Thermo Fisher Scientific, Agilent, Labcorp, More
News items for the week of Jan. 9, 2023.
In Brief This Week: MDxHealth, PerkinElmer, OpGen, Intelligent Bio Solutions, Novacyt, More
News items for the week of Oct. 24, 2022.
The company hopes that it can persuade urology practices to go with its suite of assays by covering a fuller range of treatment decision points.
MDxHealth Acquires Prostate Cancer Testing Business From Exact Sciences for up to $100M
The firm, which also reported preliminary Q2 financial results, acquired the Oncotype DX GPS test along with Exact's urology sales and marketing team.
Oct 21, 2021
MDxHealth Q3 Revenues Grow 23 Percent
Mar 3, 2021
MDxHealth 2020 Revenues Up 57 Percent
Oct 21, 2020
MDxHealth Q3 2020 Revenues Drop 6 Percent
Feb 26, 2020